| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |